Cargando…
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Chemotherapy, radiotherapy, targeted therapy, and immunotherapy have brought hope to cancer patients. With the prolongation of survival of cancer patients and increased clinical experience, cancer-therapy-induced cardiovascular toxicity has attracted attention. The adverse effects of cancer therapy...
Autores principales: | Liang, Zehua, He, Yuquan, Hu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501315/ https://www.ncbi.nlm.nih.gov/pubmed/36142538 http://dx.doi.org/10.3390/ijms231810617 |
Ejemplares similares
-
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010) -
Editorial: Cardio-oncology and reverse cardio-oncology: the manifold interconnections between heart failure and cancer
por: Ghigo, Alessandra, et al.
Publicado: (2023) -
Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018) -
The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022) -
Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)